Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Legal

Cookies

This site sets no cookie. One local-storage key records that a notice was dismissed.

§1Cookies

This site sets no cookie of any kind. It sets no analytics cookie, no preference cookie, no session cookie and no advertising identifier.

§2Local storage

Table 1. The one client-side storage item this site uses.

KeyPurposeContentsExpiry
cei_noticeRecords that the notice at the foot of the page has been dismissed, so that it is not shown again.1Persists until site data is cleared.

No other storage mechanism is used. There is no session storage, no IndexedDB, no service worker and no fingerprinting.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.